We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
(+28%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
14.34%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$9.02M |
| 2 |
Broadcom
AVGO
|
+$6.42M |
| 3 |
TSMC
TSM
|
+$6.34M |
| 4 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$6.09M |
| 5 |
Open Text
OTEX
|
+$5.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fox Class A
FOXA
|
+$9.87M |
| 2 |
Diamondback Energy
FANG
|
+$9.52M |
| 3 |
Home Depot
HD
|
+$7.05M |
| 4 |
MetLife
MET
|
+$6.8M |
| 5 |
Accenture
ACN
|
+$6.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.53% |
| 2 | Consumer Discretionary | 17.87% |
| 3 | Industrials | 15.32% |
| 4 | Healthcare | 12.76% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Union Pacific
UNP
$183B
| $1.5M | 0.19% |
7,321
-544
| -7% | -$108K |
|
152
Ares Capital
ARCC
$13.5B
| $1.5M | 0.19% |
79,608
-1,957
| -2% | -$36.1K |
|
153
LoveSac
LOVE
$239M
| $1.49M | 0.19% |
55,158
+23,486
| +74% | +$599K |
|
154
Abbott
ABT
$180B
| $1.48M | 0.19% |
13,604
+1,354
| +11% | +$144K |
|
155
Immunocore
IMCR
$1.78B
| $1.47M | 0.19% |
24,464
+4,073
| +20% | +$232K |
|
|
ROVR
156
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.45M | 0.19% |
+296,093
| New | +$1.35M |
|
157
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $1.42M | 0.18% |
30,809
| – | – |
|
158
TechnipFMC
FTI
$30.6B
| $1.42M | 0.18% |
85,285
+54,730
| +179% | +$772K |
|
|
ITCI
159
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.39M | 0.18% |
21,921
+17,515
| +398% | +$1.09M |
|
160
IPG Photonics
IPGP
$3.89B
| $1.38M | 0.18% |
+10,169
| New | +$1.2M |
|
161
Krystal Biotech
KRYS
$9.88B
| $1.37M | 0.18% |
+11,653
| New | +$1.19M |
|
162
Powell Industries
POWL
$8.46B
| $1.36M | 0.17% |
67,158
+34,962
| +109% | +$606K |
|
|
CBAY
163
DELISTED
Cymabay Therapeutics
CBAY
| $1.34M | 0.17% |
+122,233
| New | +$1.14M |
|
164
Allison Transmission
ALSN
$10.1B
| $1.34M | 0.17% |
23,671
+4,167
| +21% | +$205K |
|
165
Preformed Line Products
PLPC
$1.52B
| $1.33M | 0.17% |
+8,516
| New | +$1.24M |
|
166
Regal Rexnord
RRX
$14.2B
| $1.32M | 0.17% |
8,573
+1,269
| +17% | +$173K |
|
167
Holley
HLLY
$314M
| $1.31M | 0.17% |
320,789
+206,549
| +181% | +$616K |
|
|
BRSL
168
Brightstar Lottery PLC
BRSL
$1.91B
| $1.31M | 0.17% |
40,972
-3,142
| -7% | -$87.3K |
|
169
Blackbaud
BLKB
$1.5B
| $1.3M | 0.17% |
+18,250
| New | +$1.28M |
|
170
Vermilion Energy
VET
$1.73B
| $1.29M | 0.17% |
103,858
-6,708
| -6% | -$82.7K |
|
|
IAS
171
DELISTED
Integral Ad Science
IAS
| $1.28M | 0.16% |
71,137
+22,926
| +48% | +$387K |
|
172
NCR Voyix
VYX
$1.06B
| $1.26M | 0.16% |
+81,549
| New | +$1.18M |
|
|
FTCH
173
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.23M | 0.16% |
+204,138
| New | +$983K |
|
174
Owens Corning
OC
$11.5B
| $1.23M | 0.16% |
+9,441
| New | +$1.03M |
|
|
EEX
175
DELISTED
Emerald Holding
EEX
| $1.23M | 0.16% |
+300,000
| New | +$1.13M |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q2 2023 Portfolio in Review
As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.
- Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
- Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
- Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
- Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
- Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
- Advisory Research opened 169 new positions and closed 81 in Q2 2023.
- Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.
Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.